PTEN (inversion causing gain of an enhancer, super enhancer and eQTL in ovarian cancer), BCL2 (deletion causing gain of an eQTL and enhancer, colorectal cancer), VMP1 (inversion causing gain of an enhancer, super enhancer and eQTL in pancreatic cancer) and LSAMP (translocation causing gain of eQTL in nervous system cancer) were also significant in the same study, albeit in different cancer types. This evidence concerns the gene BCL2 and familial pancreatic carcinoma.